In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2012 |
Pennsylvania |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |
Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Validation of microRNAs as valid targets in a pediatric sarcoma |
University of Texas Southwestern Medical Center / Mark Hatley |
Young Investigator Grants |
2011 |
Texas |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |
Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia |
Fred Hutchinson Cancer Research Center / Rebecca Gardner |
Young Investigator Grants |
2011 |
Washington |
Preliminary Content Validation Steps for the Pediatric Oncology Patient Self-Report CTCAE |
Children’s National Medical Center / Pamela Hinds |
Nurse Researcher Grants |
2011 |
District of Columbia |
Phase I and II Clinical Research Program Infrastructure Award |
University of Minnesota / Brenda Weigel, MD, MSc |
Phase I/II Infrastructure Grants |
2011 |
Minnesota |
BH3 Profiling to define therapy resistance classes in neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Innovation Grants |
2011 |
Pennsylvania |